Class 2 Recall Oxoid Agglutinating Sera Salmonella 9-0 Cross-Reactivity
Summary
Remel Europe Ltd. initiated a Class 2 medical device recall for Oxoid Agglutinating Sera, Salmonella 9-0 (R30957301) affecting 16 lots distributed in the US (117 units) and internationally (950 units). The affected lots are not performing to IFU criteria, showing cross-reactions with 2-0 within 60 seconds, which may result in misidentification of a Salmonella 9-O serotype as a 2-O serotype. Consignees were notified on March 25, 2026 via urgent medical device recall letter and are advised to review results, destroy remaining inventory, and complete the acknowledgement form for replacement or credit.
“Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds.”
About this source
GovPing monitors FDA Device Recalls (Class II) for new government general regulatory changes. Every update since tracking began is archived, classified, and available as free RSS or email alerts — 79 changes logged to date.
What changed
The recall affects Oxoid Agglutinating Sera, Salmonella 9-0 (R30957301) across 16 lot codes distributed nationwide in the US (AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA) and internationally. Affected lots are not meeting instruction-for-use criteria due to cross-reactivity with the 2-0 antigen within 60 seconds, creating a risk that Salmonella 9-O serotypes could be misidentified as 2-O serotypes.\n\nClinical laboratories using this antisera product should immediately quarantine and destroy any remaining inventory of affected lots, refrain from using the product for diagnostic testing, and contact the recalling firm at 800-2556730 to complete the acknowledgement form for replacement or credit. Laboratories that have already obtained test results using affected lots should review those results for potential misclassification.
What to do next
- Review results and destroy any remaining inventory of affected lots
- Affected lots should not be used for any clinical laboratory testing
- Complete and return the acknowledgement form for replacement or credit to be processed
Archived snapshot
Apr 24, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Class 2 Device Recall Oxoid Agglutinating Sera, Salmonella 90
- Databases
| 510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards |
| CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC | |
| New Search | ) |
| | Class 2 Device Recall Oxoid Agglutinating Sera, Salmonella 90 | |
| Date Initiated by Firm | March 25, 2026 |
|---|---|
| Date Posted | April 22, 2026 |
| Recall Status | Open , Classified |
| Recall Number | Z-1923-2026 |
| Recall Event ID | 98652 |
| Product Classification | Antisera, all groups, salmonella spp. - Product Code GRM |
| Product | Oxoid Agglutinating Sera, Salmonella 9-0 |
| R30957301 | |
| Code Information | UDI-DI 05056080500270 |
| lots 6172600, 6172741, 6171393, 6150168, 6107767, 3766399, 3766400, 3780497, 3719592, 3709358, 6266130, 6253410, 6260215, 6222350, 6233859, 6233858 | |
| FEI Number | 3003750284 |
| Recalling Firm/ | |
| Manufacturer | Remel Europe Ltd. |
Clipper Boulevard West
Ken
Dartford United Kingdom |
| For Additional Information Contact | Erica Knox
800-2556730 |
| Manufacturer Reason
for Recall | Affected lots are not performing to IFU criteria showing cross reactions with 2-0 within 60 seconds. Cross-reactivity may result in the misidentification of a Salmonella 9-O serotype as a 2-O serotype. |
| FDA Determined
Cause | Under Investigation by firm |
| Action | Firm began notifying consignees on March 25, 2026 via letters titled "Urgent: Medical Device Recall."
Laboratory professionals are advised to review results and destroy any remaining inventory of affected lots. Affected lots should not be used for any clinical laboratory testing. Customers should complete and return the included acknowledgement form for replacement/credit to be processed. Notice should be passed on to all who need to be aware.
Firm is investigating the root cause and will implement corrective and preventive actions to prevent future recurrence. |
| Quantity in Commerce | 117 US; 950 OUS |
| Distribution | Worldwide - US Nationwide distribution to the states of AL, CA, FL, IA, IL, IN, MI, MN, MO, NC, NE, OH, SD, TX, WA. |
| Total Product Life Cycle | TPLC Device Report |
| 1 A record in this database is created when a firm initiates a correction or removal action. The record is updated if the FDA identifies a violation and classifies the action as a recall, and it is updated for a final time when the recall is terminated. Learn more about medical device recalls.
2 Per FDA policy, recall cause determinations are subject to modification up to the point of termination of the recall.
3 The manufacturer has initiated the recall and not all products have been corrected or removed. This record will be updated as the status changes. | |
Mentioned entities
Parties
Related changes
Get daily alerts for FDA Device Recalls (Class II)
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from FDA.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when FDA Device Recalls (Class II) publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.